What is the recommended protocol for tapering off trazodone (antidepressant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone Tapering Protocol

Trazodone should be gradually tapered rather than abruptly discontinued, with a recommended tapering schedule of 10% reduction per week or 10% per month for longer-term users, with adjustments based on patient tolerance and withdrawal symptoms. 1

Recommended Tapering Approach

  • The FDA drug label explicitly states that trazodone should be gradually reduced rather than stopped abruptly whenever possible to avoid discontinuation symptoms 1
  • Initial reductions should be small (5-10% of current dose) to build patient confidence in the process and minimize withdrawal symptoms 2
  • Each new dose should be 90% of the previous dose rather than a straight-line taper from the starting dose 2
  • For patients on long-term trazodone therapy, slower tapers (10% per month or slower) are more appropriate than faster tapers 2, 3
  • The tapering process may take several months depending on the initial dose and duration of treatment 2

Managing Withdrawal Symptoms

  • Trazodone withdrawal can cause physical and psychological symptoms including anxiety, irritability, insomnia, and general discomfort 3
  • Withdrawal symptoms can occur despite gradual discontinuation, suggesting the need for very slow tapering rates 3
  • The short half-life of trazodone and its metabolite m-chlorophenylpiperazine may contribute to withdrawal symptoms, requiring more gradual dose reductions 3
  • Adjunctive medications may be helpful for managing specific withdrawal symptoms:
    • For insomnia: Consider temporary use of alternative sleep aids 2
    • For anxiety or irritability: Short-term supportive interventions may be beneficial 2, 4

Important Considerations

  • Discontinuation symptoms are generally mild and self-limiting but can be distressing and impact daily functioning 4
  • If withdrawal symptoms become severe, consider temporarily returning to the previous dose and then resuming tapering at a slower rate 2, 4
  • The target dose may not necessarily be zero; some patients may benefit from continuing at a lower maintenance dose 2
  • Close monitoring and support during the tapering process are critical to success 2
  • Withdrawal symptoms can be mistaken for recurrence of the original condition (depression, insomnia), potentially leading to unnecessary long-term medication 4, 5

Practical Implementation

  • Start with very small dose reductions (5% of current dose) if the patient is anxious about tapering or has previously experienced withdrawal symptoms 2
  • For patients on higher doses, consider tapering to 50% of the original dose before implementing the 10% reduction schedule 2
  • Hyperbolic tapering (making proportionally smaller reductions as the dose gets lower) may be more effective than linear tapering for minimizing withdrawal symptoms 5
  • If the patient is also taking benzodiazepines, address the benzodiazepine taper first due to the higher risks associated with benzodiazepine withdrawal 6

By following this gradual tapering approach and providing appropriate support for withdrawal symptoms, most patients can successfully discontinue trazodone with minimal discomfort and reduced risk of relapse.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mechanisms of the development of trazodone withdrawal symptoms.

International clinical psychopharmacology, 1994

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Guideline

Benzodiazepine Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.